FDXR and autoimmune disease: We also found that several PA-N-CoV1804 antibodies exhibited potent anti-dsDNA reactivity and characteristic ANoA activity that resemble autoantibodies observed in patients with autoimmune diseases (Pinnas et al, 1973; Reveille et al, 2003; Rahman & Isenberg, 2008).